A manganese-based catalyst invented by chemists in Illinois could transform the solubility of drug candidates and improve their therapeutic properties.
UK process technologies firm Reaxa has received a £146K (€164K) R&D grant from the Northwest Regional Development Agency (NWDA) to scale-up production of its EnCat nickel catalyst.
Researchers believe they are a step closer to creating superefficient industrial catalysts after a team made platinum-on-gold bimetallic nanorods that are soluble in organic solvents.
New research suggests that deuteration, the replacement of hydrogen atoms with heavier forms, can alter an API's crystallisation properties and help drugmakers make better more effective drugs.
ZaCh Systems has acquired PPG Industries' fine chemicals business
for approximately $65m (€46.9m), which includes a pharmaceutical
fine chemicals facility in Texas.
British chemical products and technologies firm Reaxa has launched
a new encapsulated catalyst for market trials. Platinum EnCat is a
platinum nanoparticle catalyst encapsulated within polymer beads,
intended for the hydrogenation...
Silicone product provider Busak and Shamban, showcased a variety of
solutions at this year's Interphex event, highlighting the
stringent demands made by the pharma industry are met by its range
of sealing and bearing products.
German chemical company BASF has completed its acquisition of
Orgamol, a transaction designed to boost its service offering to
the pharmaceutical sector.
US drug researchers have synthesised a new class of carbenes -
molecules that have unusual carbon atoms - that is expected to have
wide applications in the pharmaceutical industry, ultimately
resulting in a reduction in the price...
BASF, the world's largest chemical company, said on Friday it plans
to buy Orgamol SA of Switzerland as part of an expansion of its
BASF Pharma Solutions unit, reports Phil Taylor.
Canadian researchers have a developed a new chemical reaction that
could greatly accelerate pharmaceutical production, while also
cutting costs and toxic by-products.
UK speciality chemicals firm C6 Solutions has said that it will be
stopping production operations by the end of 2005 and has put its
entire manufacturing plant and equipment up for sale.
Danish researchers have come up with a virtual model for catalyst
research that could do away with the need for large, expensive
screening experiments.
